Skip to main content
OpenTrials
Completed

NCT Number: NCT05911373

Serratus Plane Block Versus Serratus Plane Block Plus Parasternal Block Combination for Breast Surgery

Mastectomy is a technique often used in breast cancer surgery. Patients experience moderate to severe pain postoperatively after this procedure. Various plane blocks, NSAIDs, and opioid analgesics can be administered to these patients as components of multimodal analgesia. In the the study, the investigators aimed to evaluate the analgesic effects of the serratus plane block, the parasternal block added to the serratus plane block, and the dermatomal differences.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Analgesia Agnosia Breast Diseases Breast Neoplasms Cancer, Breast Neoplasms Neoplasms by Site Nervous System Diseases Neurobehavioral Manifestations Neurologic Manifestations Pathological Conditions, Signs and Symptoms Perceptual Disorders Signs and Symptoms Skin Diseases Skin and Connective Tissue Diseases

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Ali Ahiskalioglu

Erzurum, 25100, Turkey (Türkiye)

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • American Society of Anesthesiologist's physiologic state I-III patients
  • To undergo Mastectomy Surgery
  • Being between the ages of 18-65 years

Exclusion criteria

  • Having a known heart, kidney, liver or hematological disease
  • Having a history of peptic ulcer, gastrointestinal bleeding, allergy, chronic pain
  • Routine analgesic use and history of analgesic use in the last 24 hours
  • Not willing to participate in the study
  • Uncooperative patients who have coagulopathy or use anticoagulant drugs
  • To be allergic to one of the drugs to be used

Treatment and study plan

group serratus plan block

Other

preoperativelly, Superficial Serratus Block performed with 30 ml %0.25 Bupivacaine and Parasternal Block performed with 10 ml saline

group serratus and parasternal plan block

Other

preoperativelly, Superficial Serratus Block performed with 30 ml %0.25 Bupivacaine and Parasternal Block performed with 10 ml %0.25 Bupivacaine

Primary outcomes

  1. Postoperative opioid consumption

    Time frame: first 24 hours

    First 24 hours total fentanyl consumption with patient controlled analgesia

Secondary outcomes

  1. Visual analog pain score

    Time frame: First 24 hours

    Post operative pain will be evaluated with a Visual Analogue Scale (between 0-10; 0: no pain, 10:worst pain) score

  2. Sensory Assessment

    Time frame: 24 hours

    Sensory Assessment will be performed on patients following the block procedure with pinprick test.

Sponsors and collaborators

Lead sponsor

Ataturk University

Other

Registry information

Official study title

Serratus Plane Block Versus Serratus Plane Block Plus Parasternal Block on Postoperative Opioid Consumption and Dermatomal Analyses for Breast Surgery

Important dates

Study start
2023
Primary completion
2024
Study completion
2024
First posted
Jun 22, 2023
Registry last updated
Apr 1, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.